查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623473

全球锤状趾市场规模（按类型、诊断、治疗、最终用户、区域覆盖和预测）

Global Hammertoe Market Size By Type, By Diagnosis, By Treatment, By End User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

锤状趾的市场规模及预测

预计锤状趾市场规模将在2024 年达到126.9 亿美元，到2031 年将达到298.8 亿美元，在2024-2031 年预测期内的复合年增长率为11.30%。 1。

推动全球锤状趾市场发展的因素

锤状趾市场的市场推动因素可能受到多种因素的影响。

发生率增加：

人口老化、久坐的生活方式和不合适的鞋子选择是导致锤状趾病发病率上升的主要因素。

技术开发：

先进的骨科设备的发展和微创手术技术的进步正在扩大可用治疗的范围，有助于扩大市场。

提高认识与诊断：

对足部异常的瞭解不断增加，以及诊断工具的改进，使得人们能够更早地发现和治疗锤状趾，这推动了需求的不断增长。

偏好非侵入性治疗：

市场推动因素是患者对夹板和牙套等微创和非侵入性治疗的偏好日益增加。

增加医疗支出：

全球医疗支出的不断增长以及医疗设施的不断增加使得锤状趾患者可以获得替代治疗方法，从而推动了市场扩张。

限制全球锤状趾市场的因素

锤状趾市场存在一些限制和课题。

高昂的医疗费用：

治疗锤状趾的费用（包括手术、支架和后续护理）对某些患者来说可能过于昂贵，这可能会限制市场扩张。

付款规则限制：

保险覆盖不足或锤状趾治疗程序和设备的报销有限可能会阻止患者接受所需的护理，从而阻碍市场扩张。

后果与风险

儘管治疗方法已经改进，但治疗锤状趾仍存在固有的风险和潜在的后果。这些包括神经损伤、感染和復发。结果，患者可能不太愿意接受治疗，从而阻碍市场成长。

替代治疗方案：

对某些人来说，物理治疗、针灸和家庭疗法等替代疗法可能比传统的锤状趾治疗更有效。这反过来可能会减少对医疗干预的需求，影响市场成长。

发展中地区的知识差距：

由于缺乏对锤状趾问题和治疗的瞭解，尤其是在发展中地区，患者可能会放弃及时就医或转向传统治疗。这可能会阻碍市场的成长。

目录

第 1 章 全球锤状趾市场简介

  • 市场定义
  • 市场区隔
  • 调查安排
  • 先决条件
  • 限制

第 2 章：经过验证的市场研究方法

  • 资料探勘
  • 数据三角测量
  • 由下而上的方法
  • 自上而下的方法
  • 调查流程
  • 产业专家的重要见解
  • 资料来源

第 3 章执行摘要

    市场概况
  • 生态製图
  • 绝对的获利机会
  • 市场吸引力
  • 全球锤状趾市场区域分析
  • 全球锤状趾市场按类型划分
  • 全球锤状趾市场（依诊断）
  • 全球锤状趾市场（依治疗方法划分）
  • 全球锤状趾市场（以最终用户划分）
  • 未来市场机会
  • 全球市场划分
  • 产品生命线

第 4 章 全球锤状趾市场展望

  • 全球水产养殖疫苗的发展
  • 驱动程式
  • 阻碍因素
  • 机会
  • 波特五力模型
  • 价值链分析
  • 价格分析
  • 宏观经济分析

第5章 全球锤状趾市场按类型

  • 概述
  • 柔韧趾（锤状趾）
  • 锤状趾

第6章 全球锤状趾市场（依诊断）

  • 概述
  • 健康检查
  • X射线检查
  • 其他

第7章 全球锤状趾市场（依治疗方法）

  • 概述
  • 药品
  • 义肢
  • 手术
  • 其他

第8章 全球锤状趾市场（依最终用户划分）

  • 概述
  • 医院
  • 诊所
  • 物理治疗和骨科中心

第9章 全球锤状趾市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
    • 阿拉伯联合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第 10 章全球锤状趾市场的竞争格局

  • 概述
  • 各公司的市场排名
  • 重大进展
  • 公司的地理分布
  • 公司依行业分布
  • ACE 矩阵

第 11 章 公司简介

  • BioPro
  • Instratek
  • Stryker
  • Extremity Medical LLC
  • Arrowhead Medical Device Technologies
  • Wright Medical Group N.V.
  • Nextremity Solutions
  • Biometmith & Nephew plc.
  • Biomet, Inc.
  • Acumed

第 12 章 经过验证的市场情报

    关于经过验证的市场情报
  • 动态资料视觉化
简介目录
Product Code: 23821

Hammertoe Market Size And Forecast

Hammertoe Market size was valued at USD 12.69 Billion in 2024 and is projected to reach USD 29.88 Billion by 2031 , growing at a CAGR of 11.30% during the forecast period 2024-2031.

Global Hammertoe Market Drivers

The market drivers for the Hammertoe Market can be influenced by various factors. These may include:

Growing Incidence Rates:

The aging population, sedentary lifestyles, and inappropriate footwear choices are major contributors to the rising incidence of hammertoe diseases.

Technological developments:

The creation of sophisticated orthopaedic equipment and advances in minimally invasive surgical methods are broadening the range of available treatments, which is propelling market expansion.

Increasing Awareness and Diagnosis:

Better diagnostic tools along with increased knowledge of foot abnormalities are enabling early identification and management of hammertoe, which is driving greater demand.

Preference for Non-Invasive Treatments:

The market is driven by patients' increasing preference for minimally invasive or non-invasive treatment choices, such as splints and orthotic devices.

Growing Healthcare Expenditure:

The global increase in healthcare spending, together with the development of healthcare facilities, is making it easier for people with hammertoes to receive treatment alternatives, which is driving the market's expansion.

Global Hammertoe Market Restraints

Several factors can act as restraints or challenges for the Hammertoe Market. These may include:

Exorbitant therapy Costs:

Some patients may find the costs of hammertoe therapy, which include surgery, orthotic devices, and follow-up care, to be unaffordable, which could restrict market expansion.

Restricted payment rules:

Patients may be discouraged from seeking essential care, which could impede market expansion, if there is insufficient insurance coverage or restricted payment rules for hammertoe treatment procedures and devices.

consequences and Risks

: Although treatment methods have improved, hammertoe procedures still have certain inherent risks and potential consequences. These include nerve injury, infection, and recurrence. As a result, patients may be discouraged from undertaking treatment, which could hinder market growth.

Alternative Therapy Options:

For certain patients, alternative therapies including physical therapy, acupuncture, and home remedies may be more effective than traditional hammertoe treatments. This could lower the need for medical interventions and have an impact on the growth of the market.

Lack of Knowledge in Developing Areas:

Patients may choose to forego prompt medical assistance or turn to traditional remedies due to a lack of knowledge regarding hammertoe problems and treatment alternatives, especially in developing areas. This can impede market growth.

Global Hammertoe Market Segmentation Analysis

Global Hammertoe Market is Segmented based on the Type, Diagnosis, Treatment, End User, And Geography.

By Type

Flexible hammertoe

Rigid hammertoe

Based on the type, the market is bifurcated into Flexible hammertoe and Rigid hammertoe. The flexible hammertoe is when the toe can still be moved while rigid hammertoe is a condition when the toe becomes rigid & they press the joint out of alignment.

By Diagnosis

Physical exam

X-rays

Others

Based on the diagnosis, the market is bifurcated into a Physical exam, X-rays, and Others. The growing number of hammertoe correction surgeries is predicted to bolster the market in the coming years.

By Treatment

Drugs

Orthotic Devices

Surgery

Others

Based on treatment, the market is bifurcated into Drugs, Orthotic Devices, Surgery, and Others. The surgery sector is anticipated to have the biggest market share. The variables are attributable to the rise in hammertoe procedures.

By End-User

Hospitals

Clinics

Physiotherapy & Orthopedic Centers

Based on the end-user, the market is bifurcated into Hospitals, Clinics, and Physiotherapy & Orthopedic Centers. The hospital segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the increasing number of patients with capsular tears & fractures and the rise in the number of orthopedic surgeries.

By Geography

North America

Europe

Asia Pacific

Rest of the world

Based on the geographical analysis, the market is bifurcated into North America, Europe, Asia Pacific, and Rest of the world. The largest share in the market will be dominated by North America owing to the rising number of orthopedic specialty care centers & trauma care centers and the growth in the number of players manufacturing hammertoe correction products in this region.

Key Players

The major players in the Hammertoe Market are:

Stryker

Ex Extremity Medical LLC

Smith & Nephew plc

Zimmer Biomet (formerly Biomet)

Arthrex

Wright Medical Group N.V.

Acumed

OsteoMed

Nextremity Solutions, Inc.

Instratek

Extremity Medical LLC

Arrowhead Medical Device Technologies

Nextremity Solutions

Biometmith & Nephew plc.

Biomet, Inc.

Acumed.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL HAMMERTOE MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Hammertoe Market Geographical Analysis (CAGR %)
  • 3.6 Global Hammertoe Market, By Type (USD Million)
  • 3.7 Global Hammertoe Market, By Diagnosis (USD Million)
  • 3.8 Global Hammertoe Market, By Treatment (USD Million)
  • 3.9 Global Hammertoe Market, By End-User (USD Million)
  • 3.10 Future Market Opportunities
  • 3.11 Global Market Split
  • 3.12 Product Life Line

4 GLOBAL HAMMERTOE MARKET OUTLOOK

  • 4.1 Global Aquaculture Vaccines Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL HAMMERTOE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Flexible hammertoe
  • 5.3 Rigid hammertoe

6 GLOBAL HAMMERTOE MARKET, BY DIAGNOSIS

  • 6.1 Overview
  • 6.2 Physical exam
  • 6.3 X-rays
  • 6.4 Others

7 GLOBAL HAMMERTOE MARKET, BY TREATMENT

  • 7.1 Overview
  • 7.2 Drugs
  • 7.3 Orthotic Devices
  • 7.4 Surgery
  • 7.5 Others

8 GLOBAL HAMMERTOE MARKET, BY END-USER

  • 8.1 Overview
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Physiotherapy & Orthopedic Centers

9 GLOBAL HAMMERTOE MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 UAE
    • 9.6.2 Saudi Arabia
    • 9.6.3 South Africa
    • 9.6.4 Rest of Middle-East and Africa

10 GLOBAL HAMMERTOE MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Developments
  • 10.4 Company Regional Footprint
  • 10.5 Company Industry Footprint
  • 10.6 ACE Matrix

11 COMPANY PROFILES

  • 11.1 BioPro
    • 11.1.1 Company Overview
    • 11.1.2 Company Insights
    • 11.1.3 Product Benchmarking
    • 11.1.4 Key Developments
    • 11.1.5 Winning Imperatives
    • 11.1.6 Current Focus & Strategies
    • 11.1.7 Threat from Competition
    • 11.1.8 SWOT Analysis
  • 11.2 Instratek
    • 11.2.1 Company Overview
    • 11.2.2 Company Insights
    • 11.2.3 Product Benchmarking
    • 11.2.4 Key Developments
    • 11.2.5 Winning Imperatives
    • 11.2.6 Current Focus & Strategies
    • 11.2.7 Threat from Competition
    • 11.2.8 SWOT Analysis
  • 11.3 Stryker
    • 11.3.1 Company Overview
    • 11.3.2 Company Insights
    • 11.3.3 Product Benchmarking
    • 11.3.4 Key Developments
    • 11.3.5 Winning Imperatives
    • 11.3.6 Current Focus & Strategies
    • 11.3.7 Threat from Competition
    • 11.3.8 SWOT Analysis
  • 11.4 Extremity Medical LLC
    • 11.4.1 Company Overview
    • 11.4.2 Company Insights
    • 11.4.3 Product Benchmarking
    • 11.4.4 Key Developments
    • 11.4.5 Winning Imperatives
    • 11.4.6 Current Focus & Strategies
    • 11.4.7 Threat from Competition
    • 11.4.8 SWOT Analysis
  • 11.5 Arrowhead Medical Device Technologies
    • 11.5.1 Company Overview
    • 11.5.2 Company Insights
    • 11.5.3 Product Benchmarking
    • 11.5.4 Key Developments
    • 11.5.5 Winning Imperatives
    • 11.5.6 Current Focus & Strategies
    • 11.5.7 Threat from Competition
    • 11.5.8 SWOT Analysis
  • 11.6 Wright Medical Group N.V.
    • 11.6.1 Company Overview
    • 11.6.2 Company Insights
    • 11.6.3 Product Benchmarking
    • 11.6.4 Key Developments
    • 11.6.5 Winning Imperatives
    • 11.6.6 Current Focus & Strategies
    • 11.6.7 Threat from Competition
    • 11.6.8 SWOT Analysis
  • 11.7 Nextremity Solutions
    • 11.7.1 Company Overview
    • 11.7.2 Company Insights
    • 11.7.3 Product Benchmarking
    • 11.7.4 Key Developments
    • 11.7.5 Winning Imperatives
    • 11.7.6 Current Focus & Strategies
    • 11.7.7 Threat from Competition
    • 11.7.8 SWOT Analysis
  • 11.8 Biometmith & Nephew plc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Insights
    • 11.8.3 Product Benchmarking
    • 11.8.4 Key Developments
    • 11.8.5 Winning Imperatives
    • 11.8.6 Current Focus & Strategies
    • 11.8.7 Threat from Competition
    • 11.8.8 SWOT Analysis
  • 11.9 Biomet, Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Insights
    • 11.9.3 Product Benchmarking
    • 11.9.4 Key Developments
    • 11.9.5 Winning Imperatives
    • 11.9.6 Current Focus & Strategies
    • 11.9.7 Threat from Competition
    • 11.9.8 SWOT Analysis
  • 11.10 Acumed
    • 11.10.1 Company Overview
    • 11.10.2 Company Insights
    • 11.10.3 Product Benchmarking
    • 11.10.4 Key Developments
    • 11.10.5 Winning Imperatives
    • 11.10.6 Current Focus & Strategies
    • 11.10.7 Threat from Competition
    • 11.10.8 SWOT Analysis

12 VERIFIED MARKET INTELLIGENCE

  • 12.1 About Verified Market Intelligence
  • 12.2 Dynamic Data Visualization